These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 35253754)

  • 1. Targeted Metabolomic Analysis in Alzheimer's Disease Plasma and Brain Tissue in Non-Hispanic Whites.
    Kalecký K; German DC; Montillo AA; Bottiglieri T
    J Alzheimers Dis; 2022; 86(4):1875-1895. PubMed ID: 35253754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysregulation of multiple metabolic networks related to brain transmethylation and polyamine pathways in Alzheimer disease: A targeted metabolomic and transcriptomic study.
    Mahajan UV; Varma VR; Griswold ME; Blackshear CT; An Y; Oommen AM; Varma S; Troncoso JC; Pletnikova O; O'Brien R; Hohman TJ; Legido-Quigley C; Thambisetty M
    PLoS Med; 2020 Jan; 17(1):e1003012. PubMed ID: 31978055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unbiased Metabolomic Investigation of Alzheimer's Disease Brain Points to Dysregulation of Mitochondrial Aspartate Metabolism.
    Paglia G; Stocchero M; Cacciatore S; Lai S; Angel P; Alam MT; Keller M; Ralser M; Astarita G
    J Proteome Res; 2016 Feb; 15(2):608-18. PubMed ID: 26717242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Widely targeted metabolomics of Alzheimer's disease postmortem cerebrospinal fluid based on 9-fluorenylmethyl chloroformate derivatized ultra-high performance liquid chromatography tandem mass spectrometry.
    Muguruma Y; Tsutsui H; Noda T; Akatsu H; Inoue K
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Aug; 1091():53-66. PubMed ID: 29852382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain and blood metabolome for Alzheimer's dementia: findings from a targeted metabolomics analysis.
    Huo Z; Yu L; Yang J; Zhu Y; Bennett DA; Zhao J
    Neurobiol Aging; 2020 Feb; 86():123-133. PubMed ID: 31785839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study.
    Varma VR; Oommen AM; Varma S; Casanova R; An Y; Andrews RM; O'Brien R; Pletnikova O; Troncoso JC; Toledo J; Baillie R; Arnold M; Kastenmueller G; Nho K; Doraiswamy PM; Saykin AJ; Kaddurah-Daouk R; Legido-Quigley C; Thambisetty M
    PLoS Med; 2018 Jan; 15(1):e1002482. PubMed ID: 29370177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma metabolites distinguish dementia with Lewy bodies from Alzheimer's disease: a cross-sectional metabolomic analysis.
    Pan X; Donaghy PC; Roberts G; Chouliaras L; O'Brien JT; Thomas AJ; Heslegrave AJ; Zetterberg H; McGuinness B; Passmore AP; Green BD; Kane JPM
    Front Aging Neurosci; 2023; 15():1326780. PubMed ID: 38239488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Community-Based Study Identifying Metabolic Biomarkers of Mild Cognitive Impairment and Alzheimer's Disease Using Artificial Intelligence and Machine Learning.
    Yilmaz A; Ustun I; Ugur Z; Akyol S; Hu WT; Fiandaca MS; Mapstone M; Federoff H; Maddens M; Graham SF
    J Alzheimers Dis; 2020; 78(4):1381-1392. PubMed ID: 33164929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disturbed microbial ecology in Alzheimer's disease: evidence from the gut microbiota and fecal metabolome.
    Xi J; Ding D; Zhu H; Wang R; Su F; Wu W; Xiao Z; Liang X; Zhao Q; Hong Z; Fu H; Xiao Q
    BMC Microbiol; 2021 Aug; 21(1):226. PubMed ID: 34384375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic profiling of Alzheimer's disease: Untargeted metabolomics analysis of plasma samples.
    Milos T; Rojo D; Nedic Erjavec G; Konjevod M; Tudor L; Vuic B; Svob Strac D; Uzun S; Mimica N; Kozumplik O; Barbas C; Zarkovic N; Pivac N; Nikolac Perkovic M
    Prog Neuropsychopharmacol Biol Psychiatry; 2023 Dec; 127():110830. PubMed ID: 37454721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Graded perturbations of metabolism in multiple regions of human brain in Alzheimer's disease: Snapshot of a pervasive metabolic disorder.
    Xu J; Begley P; Church SJ; Patassini S; Hollywood KA; Jüllig M; Curtis MA; Waldvogel HJ; Faull RL; Unwin RD; Cooper GJ
    Biochim Biophys Acta; 2016 Jun; 1862(6):1084-92. PubMed ID: 26957286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma metabolomics in early Alzheimer's disease patients diagnosed with amyloid biomarker.
    Peña-Bautista C; Roca M; Hervás D; Cuevas A; López-Cuevas R; Vento M; Baquero M; García-Blanco A; Cháfer-Pericás C
    J Proteomics; 2019 May; 200():144-152. PubMed ID: 30978462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic Alterations in the Outer Membrane Vesicles of Patients with Alzheimer's Disease: An LC-MS/MS-based Metabolomics Analysis.
    Wei SC; Wei W; Peng WJ; Liu Z; Cai ZY; Zhao B
    Curr Alzheimer Res; 2019; 16(13):1183-1195. PubMed ID: 31755388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global Metabolic Shifts in Age and Alzheimer's Disease Mouse Brains Pivot at NAD+/NADH Redox Sites.
    Dong Y; Brewer GJ
    J Alzheimers Dis; 2019; 71(1):119-140. PubMed ID: 31356210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The identification of a potential plasma metabolite marker for Alzheimer's disease by LC-MS untargeted metabolomics.
    Lin CH; Lin YN; Lane HY; Chen CJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2023 May; 1222():123686. PubMed ID: 37068461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted metabolomic analysis in Parkinson's disease brain frontal cortex and putamen with relation to cognitive impairment.
    Kalecký K; Bottiglieri T
    NPJ Parkinsons Dis; 2023 Jun; 9(1):84. PubMed ID: 37270646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of Hair Metabolome in 5xFAD Mice and Patients with Alzheimer's Disease Using Mass Spectrometry-Based Metabolomics.
    Chang CW; Hsu JY; Lo YT; Liu YH; Mee-Inta O; Lee HT; Kuo YM; Liao PC
    ACS Chem Neurosci; 2024 Feb; 15(3):527-538. PubMed ID: 38269400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of brain-derived extracellular vesicle lipids in Alzheimer's disease.
    Su H; Rustam YH; Masters CL; Makalic E; McLean CA; Hill AF; Barnham KJ; Reid GE; Vella LJ
    J Extracell Vesicles; 2021 May; 10(7):e12089. PubMed ID: 34012516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-resolution metabolomic profiling of Alzheimer's disease in plasma.
    Niedzwiecki MM; Walker DI; Howell JC; Watts KD; Jones DP; Miller GW; Hu WT
    Ann Clin Transl Neurol; 2020 Jan; 7(1):36-45. PubMed ID: 31828981
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.